On January 7, 2020 Nektar Therapeutics’ (Nasdaq: NKTR) President and Chief Executive Officer, Howard Robin, is reported to present at the upcoming 38th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 13, 2020 at 2:30 p.m. Pacific Time (Press release, Nektar Therapeutics, JAN 7, 2020, View Source [SID1234552821]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The presentation will be accessible via a Webcast through a link posted on the Investors, Events Calendar section of the Nektar website: View Source In addition, the company will webcast the Q&A breakout session immediately following its presentation at 3:00 p.m. Pacific Time. This Webcast will be available for replay until February 21, 2020.